Page last updated: 2024-09-05

sb 203580 and methoxamine

sb 203580 has been researched along with methoxamine in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(methoxamine)
Trials
(methoxamine)
Recent Studies (post-2010) (methoxamine)
3,48941,1372,1355782

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Michel, MC; Peters, SL; Pfaffendorf, M; Sand, C; Van Zwieten, PA1

Other Studies

1 other study(ies) available for sb 203580 and methoxamine

ArticleYear
A mitogen-activated protein kinase is involved in the inotropic but not chronotropic actions of adrenoceptor agonists and endothelin-1.
    Naunyn-Schmiedeberg's archives of pharmacology, 2002, Volume: 366, Issue:2

    Topics: Adrenergic Agonists; Adrenergic alpha-1 Receptor Agonists; Analysis of Variance; Animals; Butadienes; Endothelin-1; Enzyme Inhibitors; Flavonoids; Heart Rate; Imidazoles; Isoproterenol; Male; MAP Kinase Signaling System; Methoxamine; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Myocardial Contraction; Nitriles; Pyridines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1

2002